Loading...

GMP Capital

OTCPK:GMPX.F
Snowflake Description

Average dividend payer and fair value.

The Snowflake is generated from 30 checks in 5 different areas, read more below.
GMPX.F
OTCPK
CA$169M
Market Cap
  1. Home
  2. US
  3. Diversified Financials
Company description

GMP Capital Inc., an independent diversified financial services company, provides various financial products and services to corporate clients, institutional investors, and high-net-worth individuals in Canada, the United States, and internationally. The last earnings update was 19 days ago. More info.


Add to Portfolio Compare Print
  • GMP Capital has significant price volatility in the past 3 months.
GMPX.F Share Price and Events
7 Day Returns
-0.6%
OTCPK:GMPX.F
3.1%
US Capital Markets
1.6%
US Market
1 Year Returns
-24.9%
OTCPK:GMPX.F
-11%
US Capital Markets
3.2%
US Market
GMPX.F Shareholder Return
  7 Day 30 Day 90 Day 1 Year 3 Year 5 Year
GMP Capital (GMPX.F) -0.6% -8% - -24.9% -51.5% -74.7%
US Capital Markets 3.1% 1% 11.6% -11% 57.3% 58.2%
US Market 1.6% 2.1% 12.8% 3.2% 38.6% 43.6%
1 Year Return vs Industry and Market
  • GMPX.F underperformed the Capital Markets industry which returned -11% over the past year.
  • GMPX.F underperformed the Market in United States of America which returned 3.2% over the past year.
Price Volatility
GMPX.F
Industry
5yr Volatility vs Market

GMPX.F Value

 Is GMP Capital undervalued based on future cash flows and its price relative to the stock market?

Value is all about what a company is worth versus what price it is available for. If you went into a grocery store and all the bananas were on sale at half price, they could be considered undervalued.
INTRINSIC VALUE BASED ON FUTURE CASH FLOWS
  • It is not possible to calculate the future cash flow value for GMP Capital. This is due to cash flow or dividend data being unavailable. The share price is $1.7571.
PRICE RELATIVE TO MARKET
We can also value a company based on what the stock market is willing to pay for it. This is similar to the price of fruit (e.g. Mangoes or Avocados) increasing when they are out of season, or how much your home is worth.

The amount the stock market is willing to pay for GMP Capital's earnings, growth and assets is considered below, and whether this is a fair price.
Price based on past earnings
Are GMP Capital's earnings available for a low price, and how does this compare to other companies in the same industry?
Raw Data
OTCPK:GMPX.F PE (Price to Earnings) Ratio Data Sources
Data Point Source Value
Earnings Per Share * Company Filings (2018-12-31) in CAD CA$0.16
TSX:GMP Share Price ** TSX (2019-03-19) in CAD CA$2.33
United States of America Capital Markets Industry PE Ratio Median Figure of 76 Publicly-Listed Capital Markets Companies 24.96x
United States of America Market PE Ratio Median Figure of 3,056 Publicly-Listed Companies 17.77x

* Trailing twelve months (TTM) annual GAAP earnings per share excluding extraordinary items.

** Primary Listing of GMP Capital.

OTCPK:GMPX.F PE (Price to Earnings) Ratio Calculation
Calculation Outcome
PE Ratio

= TSX:GMP Share Price ÷ EPS (both in CAD)

= 2.33 ÷ 0.16

14.49x

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • GMP Capital is good value based on earnings compared to the US Capital Markets industry average.
  • GMP Capital is good value based on earnings compared to the United States of America market.
Price based on expected Growth
Does GMP Capital's expected growth come at a high price?
Raw Data
OTCPK:GMPX.F PEG (Price to Earnings to Growth) Ratio Data Sources
Data Point Source Value
PE Ratio See PE Ratio Section 14.49x
Net Income Annual Growth Rate See Future Growth Section.
Line of Best Fit* through Consensus Estimate Earnings of 0 Analysts
Not available
United States of America Capital Markets Industry PEG Ratio Median Figure of 33 Publicly-Listed Capital Markets Companies 2.21x
United States of America Market PEG Ratio Median Figure of 2,107 Publicly-Listed Companies 1.49x

*Line of best fit is calculated by linear regression .

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Unable to calculate PEG ratio for GMP Capital, we can't assess if its growth is good value.
Price based on value of assets
What value do investors place on GMP Capital's assets?
Raw Data
OTCPK:GMPX.F PB (Price to Book) Ratio Data Sources
Data Point Source Value
Book Value per Share Company Filings (2018-12-31) in CAD CA$2.44
TSX:GMP Share Price * TSX (2019-03-19) in CAD CA$2.33
United States of America Capital Markets Industry PB Ratio Median Figure of 149 Publicly-Listed Capital Markets Companies 4.83x
United States of America Market PB Ratio Median Figure of 5,154 Publicly-Listed Companies 1.89x
OTCPK:GMPX.F PB (Price to Book) Ratio Calculation
Calculation Outcome
PB Ratio

= TSX:GMP Share Price ÷ Book Value per Share (both in CAD)

= 2.33 ÷ 2.44

0.95x

* Primary Listing of GMP Capital.

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • GMP Capital is good value based on assets compared to the US Capital Markets industry average.
X
Value checks
We assess GMP Capital's value by looking at:
  1. Is the discounted cash flow value less than 20%, or 40% of the share price? (2 checks) ( Click here or on bar chart for details of DCF calculation. )
  2. Is the PE ratio less than the market average, and/ or less than the Capital Markets industry average (and greater than 0)? (2 checks)
  3. Is the PEG ratio within a reasonable range (0 to 1)? (1 check)
  4. Is the PB ratio less than the Capital Markets industry average (and greater than 0)? (1 check)
  5. GMP Capital has a total score of 3/6, see the detailed checks below.

    Note: We use GAAP Earnings per Share in all our calculations including PE and PEG Ratio.

    Full details on the Value part of the Simply Wall St company analysis model.

GMPX.F Future Performance

 How is GMP Capital expected to perform in the next 1 to 3 years based on estimates from 0 analysts?

In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as GMP Capital has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.

This is quite a rare situation as 97% of companies covered by Simply Wall St do have past financial data. You can see them here.

Show me the analysis anyway

The future performance of a company is measured in the same way as past performance, by looking at estimated growth and how much profit it is expected to make.

Future estimates come from professional analysts. Just like forecasting the weather, they don’t always get it right!
Annual Growth Rate
6.4%
Expected Capital Markets industry annual growth in earnings.
Earnings growth vs Low Risk Savings
Is GMP Capital expected to grow at an attractive rate?
  • Unable to compare GMP Capital's earnings growth to the low risk savings rate as no estimate data is available.
Growth vs Market Checks
  • Unable to compare GMP Capital's earnings growth to the United States of America market average as no estimate data is available.
  • Unable to compare GMP Capital's revenue growth to the United States of America market average as no estimate data is available.
Annual Growth Rates Comparison
Raw Data
OTCPK:GMPX.F Future Growth Rates Data Sources
Data Point Source Value (per year)
United States of America Capital Markets Industry Earnings Growth Rate Market Cap Weighted Average 6.4%
United States of America Capital Markets Industry Revenue Growth Rate Market Cap Weighted Average 3.8%
United States of America Market Earnings Growth Rate Market Cap Weighted Average 14.3%
United States of America Market Revenue Growth Rate Market Cap Weighted Average 7.1%

*Line of best fit is calculated by linear regression .

Industry and Market average data is calculated daily.

Learn more about our growth rate calculations in Simply Wall St’s analysis model.

Analysts growth expectations
Raw Data
OTCPK:GMPX.F Analysts Growth Expectations Data Sources
Data Point Source Value
Past Financials Company Filings (2 months ago) See Below
Future Estimates Average of up to 0 Analyst Estimates (S&P Global) See Below
All numbers in CAD Millions and using Trailing twelve months (TTM) annual period rather than quarterly.
OTCPK:GMPX.F Future Estimates Data
Date (Data in CAD Millions) Revenue Cash Flow Net Income * Avg. No. Analysts
OTCPK:GMPX.F Past Financials Data
Date (Data in CAD Millions) Revenue Cash Flow Net Income *
2018-12-31 165 -88 11
2018-09-30 204 3 10
2018-06-30 180 -57 4
2018-03-31 180 19 -51
2017-12-31 145 109 -48
2017-09-30 182 93 -54
2017-06-30 192 0 -63
2017-03-31 192 101 -9
2016-12-31 190 25 -16
2016-09-30 157 15 -35
2016-06-30 167 224 -36
2016-03-31 204 56 -30

*GAAP earnings excluding extraordinary items.

Super high growth metrics
High Growth Checks
  • Unable to determine if GMP Capital is high growth as no earnings estimate data is available.
  • Unable to determine if GMP Capital is high growth as no revenue estimate data is available.
Past and Future Earnings per Share
The accuracy of the analysts who estimate the future performance data can be gauged below. We look back 3 years and see if they were any good at predicting what actually occurred. We also show the highest and lowest estimates looking forward to see if there is a wide range.
Raw Data
OTCPK:GMPX.F Past and Future Earnings per Share
Data Point Source Value
Past Financials Company Filings (2 months ago) See Below
Future Estimates Average of up to 0 Analyst Estimates (S&P Global) See Below

All data from GMP Capital Company Filings, last reported 2 months ago, and in Trailing twelve months (TTM) annual period rather than quarterly.

OTCPK:GMPX.F Future Estimates Data
Date (Data in CAD Millions) EPS * EPS High Estimate EPS Low Estimate Avg. No. Analysts
OTCPK:GMPX.F Past Financials Data
Date (Data in CAD Millions) EPS *
2018-12-31 0.16
2018-09-30 0.14
2018-06-30 0.06
2018-03-31 -0.74
2017-12-31 -0.70
2017-09-30 -0.78
2017-06-30 -0.91
2017-03-31 -0.13
2016-12-31 -0.24
2016-09-30 -0.54
2016-06-30 -0.54
2016-03-31 -0.45

*GAAP earnings excluding extraordinary items.

Performance in 3 years
In the same way as past performance we look at the future estimated return (profit) compared to the available funds. We do this looking forward 3 years.
  • Unable to establish if GMP Capital will efficiently use shareholders’ funds in the future without estimates of Return on Equity.

Next steps:

  1. Examine whether GMP Capital is trading at GMP Capital'san attractive price based on how much it is expected to earn in the future, and relative to its industry peers and the wider market.
  2. GMP Capital's future outlook can be gauged by looking at industry trends and market size, and determining how well-positioned the company is compared to its competitors. Take a look at other high-growth Diversified Financials companies here
  3. While we do not consider unaudited financials to be a reliable enough to include in our analysis, you can access them on the OTC Markets Website. If you are looking for more of a qualitative research into the company, you can access GMP Capital's filings and announcements here.
  4. Use fundamentals to screen for another stock to analyse from our database of over 75,000 companies worldwide
X
Future performance checks
We assess GMP Capital's future performance by looking at:
  1. Is the annual earnings growth rate expected to beat the low risk savings rate, plus a premium to keep pace with inflation?
  2. Is the annual earnings growth rate expected to beat the average growth rate in earnings of the United States of America market? (1 check)
  3. Is the annual revenue growth rate expected to beat the average growth rate in revenue of the United States of America market? (1 check)
  4. Is the annual earnings growth rate expected to be above 20%? (1 check)
  5. Is the annual revenue growth rate expected to be above 20%? (1 check)
  6. Is the Return on Equity in 3 years expected to be over 20%? (1 check)
Some of the above checks will fail if the company is expected to be loss making in the relevant year.
GMP Capital has a total score of 0/6, see the detailed checks below.

Note 1: We use GAAP Net Income Excluding Exceptional Items for our Earnings in all our calculations.

Full details on the Future part of the Simply Wall St company analysis model.

GMPX.F Past Performance

  How has GMP Capital performed over the past 5 years?

The past performance of a company can be measured by how much growth it has experienced and how much profit it makes relative to the funds and assets it has available.
Past earnings growth
Below we compare GMP Capital's growth in the last year to its industry (Capital Markets).
Past Earnings growth analysis
We also check if the company has grown in the past 5 years, and whether it has maintained that growth in the year.
  • GMP Capital's year on year earnings growth rate was negative over the past 5 years, however the most recent earnings are above average.
  • GMP Capital has become profitable in the last year making the earnings growth rate difficult to compare to the 5-year average.
  • GMP Capital has become profitable in the last year making it difficult to compare the US Capital Markets industry average.
Earnings and Revenue History
GMP Capital's revenue and profit over the past 5 years is shown below, any years where they have experienced a loss will show up in red.
Raw Data

All data from GMP Capital Company Filings, last reported 2 months ago, and in Trailing twelve months (TTM) annual period rather than quarterly.

OTCPK:GMPX.F Past Revenue, Cash Flow and Net Income Data
Date (Data in CAD Millions) Revenue Net Income * G+A Expenses R&D Expenses
2018-12-31 165.48 10.89 104.35
2018-09-30 204.17 9.69 131.79
2018-06-30 179.94 4.06 117.20
2018-03-31 179.72 -50.66 119.78
2017-12-31 144.65 -48.39 93.18
2017-09-30 182.03 -54.41 123.06
2017-06-30 192.44 -62.69 122.49
2017-03-31 191.84 -8.62 119.35
2016-12-31 189.56 -16.21 123.78
2016-09-30 156.88 -35.47 115.48
2016-06-30 166.92 -35.70 134.49
2016-03-31 204.10 -29.94 157.34
2015-12-31 211.63 -34.39 167.98
2015-09-30 232.92 -25.68 176.66
2015-06-30 247.07 -9.52 176.51
2015-03-31 248.73 -3.18 174.37
2014-12-31 259.37 8.57 170.44
2014-09-30 277.19 21.09 170.33
2014-06-30 252.01 16.57 154.46
2014-03-31 231.98 2.16 146.19
2013-12-31 206.27 -1.49 139.99
2013-09-30 219.26 -0.12 151.79
2013-06-30 234.86 -1.34 168.05
2013-03-31 237.15 -1.94 173.28
2012-12-31 264.96 -2.75 187.93
2012-09-30 256.89 -6.85 185.16
2012-06-30 244.33 -10.95 176.77
2012-03-31 248.34 -4.20 170.49

*GAAP earnings excluding extraordinary items.

Performance last year
We want to ensure a company is making the most of what it has available. This is done by comparing the return (profit) to a company's available funds, assets and capital.
  • GMP Capital has not efficiently used shareholders’ funds last year (Return on Equity less than 20%).
  • GMP Capital used its assets less efficiently than the US Capital Markets industry average last year based on Return on Assets.
  • Unable to establish if GMP Capital improved its use of capital last year versus 3 years ago (Return on Capital Employed) due to insufficient past data.
X
Past performance checks
We assess GMP Capital's performance over the past 5 years by checking for:
  1. Has earnings increased in past 5 years? (1 check)
  2. Has the earnings growth in the last year exceeded that of the Capital Markets industry? (1 check)
  3. Is the recent earnings growth over the last year higher than the average annual growth over the past 5 years? (1 check)
  4. Is the Return on Equity (ROE) higher than 20%? (1 check)
  5. Is the Return on Assets (ROA) above industry average? (1 check)
  6. Has the Return on Capital Employed (ROCE) increased from 3 years ago? (1 check)
The above checks will fail if the company has reported a loss in the most recent earnings report. Some checks require at least 3 or 5 years worth of data.
GMP Capital has a total score of 0/6, see the detailed checks below.

Note: We use GAAP Net Income excluding extraordinary items in all our calculations.

Full details on the Past part of the Simply Wall St company analysis model.

GMPX.F Health

 How is GMP Capital's financial health and their level of debt?

A company's financial position is much like your own financial position, it includes everything you own (assets) and owe (liabilities).

The boxes below represent the relative size of what makes up GMP Capital's finances.

The net worth of a company is the difference between its assets and liabilities.
Net Worth
  • GMP Capital is able to meet its short term (1 year) commitments with its holdings of cash and other short term assets.
  • GMP Capital's cash and other short term assets cover its long term commitments.
Balance sheet
This treemap shows a more detailed breakdown of GMP Capital's finances. If any of them are yellow this indicates they may be out of proportion and red means they relate to one of the checks below.
Assets
Liabilities and shares
The 'shares' portion represents any funds contributed by the owners (shareholders) and any profits.
  • Low level of unsold assets.
  • Debt is covered by short term assets, assets are 55.2x debt.
Historical Debt
Nearly all companies have debt. Debt in itself isn’t bad, however if the debt is too high, or the company can’t afford to pay the interest on its debts this may have impacts in the future.

The graphic below shows equity (available funds) and debt, we ideally want to see the red area (debt) decreasing.

If there is any debt we look at the companies capability to repay it, and whether the level has increased over the past 5 years.
Raw Data

All data from GMP Capital Company Filings, last reported 2 months ago.

OTCPK:GMPX.F Past Debt and Equity Data
Date (Data in CAD Millions) Total Equity Total Debt Cash & Short Term Investments
2018-12-31 290.03 28.70 626.35
2018-09-30 295.88 28.50 793.99
2018-06-30 293.65 28.30 590.21
2018-03-31 293.37 28.11 678.54
2017-12-31 293.43 39.82 737.00
2017-09-30 284.52 39.65 639.34
2017-06-30 289.09 39.32 719.54
2017-03-31 342.06 39.00 691.94
2016-12-31 336.11 39.61 617.07
2016-09-30 334.37 38.72 534.31
2016-06-30 325.63 0.00 786.35
2016-03-31 325.72 0.00 577.60
2015-12-31 337.13 4.02 618.37
2015-09-30 350.18 3.44 612.54
2015-06-30 363.30 2.88 558.43
2015-03-31 362.96 3.71 754.97
2014-12-31 370.29 0.41 616.73
2014-09-30 389.03 0.00 576.19
2014-06-30 388.11 0.00 628.17
2014-03-31 389.25 0.00 772.93
2013-12-31 387.13 0.00 569.38
2013-09-30 351.78 0.00 397.49
2013-06-30 356.10 0.00 515.49
2013-03-31 366.94 0.00 436.20
2012-12-31 371.73 0.00 513.18
2012-09-30 368.14 0.00 467.53
2012-06-30 357.55 0.00 413.78
2012-03-31 362.19 0.00 461.96
  • GMP Capital's level of debt (9.9%) compared to net worth is satisfactory (less than 40%).
  • The level of debt compared to net worth has increased over the past 5 years (0% vs 9.9% today).
  • Operating cash flow is negative therefore debt is not well covered.
  • Unable to confirm if the interest payments on GMP Capital's debt are well covered by earnings due to lack of past financial data.
X
Financial health checks
We assess GMP Capital's financial health by checking for:
  1. Are short term assets greater than short term liabilities? (1 check)
  2. Are short term assets greater than long term liabilities? (1 check)
  3. Has the debt to equity ratio increased in the past 5 years? (1 check)
  4. Is the debt to equity ratio over 40%? (1 check)
  5. Is the debt covered by operating cash flow? (1 check)
  6. Are earnings greater than 5x the interest on debt (if company pays interest at all)? (1 check)
  7. GMP Capital has a total score of 3/6, see the detailed checks below.
For companies that are loss making and have been so on average in the past we replace the last 2 checks with:
  1. Does cash and short term investments cover stable operating expenses (recurring G&A and R&D) for more than 3 years? (1 check)
  2. Does cash and short term investments cover growing operating expenses (recurring G&A and R&D) for more than 3 years? (1 check)


Full details on the Health part of the Simply Wall St company analysis model.

GMPX.F Dividends

 What is GMP Capital's current dividend yield, its reliability and sustainability?

Dividends are regular cash payments to you from the company, similar to a bank paying you interest on a savings account.
Annual Dividend Income
Dividend payments
4.29%
Current annual income from GMP Capital dividends.
If you bought $2,000 of GMP Capital shares you are expected to receive $86 in your first year as a dividend.
Dividend Amount
Here we look how much dividend is being paid, if any. Is it above what you can get in a savings account? It is up there with the best dividend paying companies?
  • GMP Capital's pays a higher dividend yield than the bottom 25% of dividend payers in United States of America (1.44%).
  • GMP Capital's dividend is above the markets top 25% of dividend payers in United States of America (3.63%).
Annualized Historical and Future Dividends
It is important to see if the dividend for a company is stable, and not wildly increasing/decreasing each year. This graph shows you the historical rate to count toward your assessment of the stock.

We also check to see if the dividend has increased in the past 10 years.
Raw Data
OTCPK:GMPX.F Annualized Past and Future Dividends
Data Point Source Value
Past Annualized Dividend Yield S&P Global Market Data See Below
Past Dividends per Share Company Filings/ Annualized Dividend Payments See Below
Future Dividends per Share Estimates Average of up to 0 Analyst Estimates (S&P Global) See Below
United States of America Capital Markets Industry Average Dividend Yield Market Cap Weighted Average of 43 Stocks 2%
United States of America Market Average Dividend Yield Market Cap Weighted Average of 2004 Stocks 2.5%
United States of America Minimum Threshold Dividend Yield 10th Percentile 0.8%
United States of America Bottom 25% Dividend Yield 25th Percentile 1.4%
United States of America Top 25% Dividend Yield 75th Percentile 3.6%

Industry and Market average data is calculated daily.

Note all dividend per share amounts are annualized and not quarterly or other period.

OTCPK:GMPX.F Future Dividends Estimate Data
Date (Data in CA$) Dividend per Share (annual) Avg. No. Analysts
OTCPK:GMPX.F Past Annualized Dividends Data
Date (Data in CA$) Dividend per share (annual) Avg. Yield (%)
2019-03-01 0.100 4.237
2018-11-09 0.100 4.721
2017-08-04 0.000 0.000
2017-04-27 0.000 0.000
2017-03-03 0.000 0.000
2016-11-02 0.000 0.000
2016-08-05 0.000 0.000
2016-04-28 0.000 0.000
2016-04-15 0.000 0.000
2016-03-11 0.000 0.000
2015-11-06 0.200 4.827
2015-08-07 0.200 4.706
2015-04-30 0.200 3.986
2015-03-06 0.200 3.676
2014-11-07 0.200 3.511
2014-08-08 0.200 2.743
2014-05-01 0.200 2.408
2014-03-04 0.200 2.587
2013-11-08 0.200 2.925
2013-08-09 0.200 3.202
2013-05-03 0.200 3.245
2013-04-11 0.200 3.624
2013-03-01 0.200 3.152
2012-11-09 0.200 3.342
2012-08-03 0.200 3.695
2012-05-04 0.200 3.749
2012-03-14 0.400 5.854
2011-11-04 0.400 5.379
2011-08-05 0.400 5.185
2011-05-06 0.400 3.088
2011-03-02 0.320 2.081
2010-11-05 0.240 1.801
2010-08-06 0.240 2.273
2010-05-07 0.200 2.014
2010-03-02 0.200 1.484
2009-11-05 0.200 1.617
2009-06-18 0.200 1.654
2009-03-23 0.000 0.000

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Dividends per share have been stable in the past 10 years.
  • Dividends per share have fallen over the past 10 years.
Current Payout to shareholders
What portion of GMP Capital's earnings are paid to the shareholders as a dividend.
  • Dividends paid are well covered by earnings (6.4x coverage).
Future Payout to shareholders
  • Insufficient estimate data to determine if a dividend will be paid in 3 years and that it will be sustainable.
X
Income/ dividend checks
We assess GMP Capital's dividend by checking for:
  1. Firstly is the company paying a notable dividend (greater than 0.8%) - if not then the rest of the checks are ignored.
  2. Is current dividend yield above the bottom 25% of dividend payers? (1 check)
  3. Is current dividend yield above the top 25% of dividend payers? (1 check)
  4. Have they paid a dividend for 10 years, and during this period has the dividend been volatile (drop of more than 25%)? (1 check)
  5. If they have paid a dividend for 10 years has it increased in this time? (1 check)
  6. How sustainable is the dividend, can GMP Capital afford to pay it from its earnings today and in 3 years (Payout ratio less than 90%)? (2 checks)
  7. GMP Capital has a total score of 4/6, see the detailed checks below.


Full details on the Dividends part of the Simply Wall St company analysis model.

GMPX.F Management

 What is the CEO of GMP Capital's salary, the management and board of directors tenure and is there insider trading?

Management is one of the most important areas of a company. We look at unreasonable CEO compensation, how long the team and board of directors have been around for and insider trading.
CEO
Harris Fricker
COMPENSATION CA$3,300,796
AGE 53
TENURE AS CEO 8.4 years
CEO Bio

Mr. Harris A. Fricker, B.A., M.A., has been the Chief Executive Officer of GMP Capital Inc. since October 1, 2010 and has been its President since May 2009. Mr. Fricker serves as the President of Griffiths McBurney L.P. He has been the President of Griffiths McBurney Canada Corp., Administrator of GMP Capital Trust since July 7, 2008 and also serves as its Head of Investment Banking. He served as the President of GMP Securities L.P., a subsidiary of GMP Capital Trust since July 2008 and served as its Managing Director and Co-Head of Investment Banking. He served as Managing Director of GMP Securities Ltd and served as its President since July 2008. He also served as President and Co-Head of Invemstment Banking of GMP Corp. Mr. Fricker served as the Head of Investment Banking of GMP Securities Europe LLP. He was responsible for investment banking in Toronto and Montreal for GMP Securities, where he is closely involved in the day- to-day corporate finance coverage of the industrial products and industrial technology sectors. Mr. Fricker joined GMP in March 2002. He has over a decade of investment banking experience in the North American capital markets. He Founded, funded and operated his own investment management company in the Unites States. He served a variety of senior roles with major Canadian investment dealers, including institutional sales and trading, corporate finance and debt capital markets. He served as Vice Chairman of GMP Corp. Mr. Fricker served as Co-Chairman of GMP Securities Europe LLP. He served as Vice-Chairman of GMP Securities L.P. He served as Vice Chairman of Griffiths McBurney Canada Corp. He has been a Director of GMP Capital Inc. since October 1, 2010. He serves as a Director of Academy Of Canadian Cinema And Television. Mr. Fricker serves as Director at Richardson GMP Limited. Mr. Fricker holds a BA from Saint Francis Xavier University and an MA from Oxford University, which he attended as a Rhodes Scholar.

CEO Compensation
  • Harris's compensation has been consistent with company performance over the past year.
  • Harris's remuneration is higher than average for companies of similar size in United States of America.
Management Team Tenure

Average tenure of the GMP Capital management team in years:

6.5
Average Tenure
  • The average tenure for the GMP Capital management team is over 5 years, this suggests they are a seasoned and experienced team.
Management Team

Harris Fricker

TITLE
President
COMPENSATION
CA$3M
AGE
53
TENURE
8.4 yrs

Gene McBurney

TITLE
Director
COMPENSATION
CA$2M
AGE
69

Debbie Starkman

TITLE
CFO & Corporate Secretary
COMPENSATION
CA$1M
TENURE
6.5 yrs

Chris Bond

TITLE
Vice Chairman & Head of Institutional Trading of GMP Securities
COMPENSATION
CA$2M

Rob Weir

TITLE
Vice Chairman & Head of Institutional Equity Sales of GMP Securities
COMPENSATION
CA$2M

Rocco Colella

TITLE
Director of Investor Relations

Chris Hill

TITLE
Chief Compliance Officer

John Chambers

TITLE
Vice Chairman & President of GMP FirstEnergy
TENURE
2.4 yrs

Daryl Rudichuk

TITLE
Managing Director

Steve Harris

TITLE
Vice Chairman & Head of Research of GMP Securities
Board of Directors Tenure

Average tenure and age of the GMP Capital board of directors in years:

5.2
Average Tenure
62
Average Age
  • The tenure for the GMP Capital board of directors is about average.
Board of Directors

Don Wright

TITLE
Chairman of the Board
COMPENSATION
CA$185K
AGE
70

Harris Fricker

TITLE
President
COMPENSATION
CA$3M
AGE
53
TENURE
8.4 yrs

Kevin Sullivan

TITLE
Deputy Chairman
COMPENSATION
CA$1M
AGE
58
TENURE
8.4 yrs

Gene McBurney

TITLE
Director
COMPENSATION
CA$2M
AGE
69
TENURE
10.8 yrs

Fiona Macdonald

TITLE
Independent Director
COMPENSATION
CA$112K
AGE
63
TENURE
5.6 yrs

David Ferguson

TITLE
Director
COMPENSATION
CA$141K
AGE
66
TENURE
4.6 yrs

Dave Brown

TITLE
Director
COMPENSATION
CA$97K
AGE
58
TENURE
4.8 yrs

Kish K. Kapoor

TITLE
Independent Board Member
AGE
61
TENURE
0.8 yrs

Julie A. Lassonde

TITLE
Independent Director
TENURE
0.5 yrs
Who owns this company?
Recent Insider Trading
  • No 3 month insider trading information.
Recent Insider Transactions
Announced Type Name Entity Role Start End Shares Max Price ($) Value ($)
X
Management checks
We assess GMP Capital's management by checking for:
  1. Is the CEO's compensation unreasonable compared to market cap? (1 check)
  2. Has the CEO's compensation increased more than 20% whilst the EPS is down more then 20%? (1 check)
  3. Is the average tenure of the management team less than 2 years? (1 check)
  4. Is the average tenure of the board of directors team less than 3 years? (1 check)
  5. GMP Capital has a total score of 0/6, this is not included on the snowflake, see the detailed checks below.


Note: We use the top 6 management executives and board members in our calculations.

Note 2: Insider trading include any internal stakeholders and these transactions .

Full details on the Management part of the Simply Wall St company analysis model.

GMPX.F News

Simply Wall St News

GMPX.F Company Info

Description

GMP Capital Inc., an independent diversified financial services company, provides various financial products and services to corporate clients, institutional investors, and high-net-worth individuals in Canada, the United States, and internationally. It operates in two segments, Capital Markets and Wealth Management. The Capital Markets segment offers investment banking services, including advisory and underwriting services, institutional research and sales, and trading services. The Wealth Management segment provides wealth management and investment services. GMP Capital Inc. was founded in 1995 and is headquartered in Toronto, Canada.

Details
Name: GMP Capital Inc.
GMPX.F
Exchange: OTCPK
Founded: 1995
CA$127,349,929
72,721,182
Website: http://www.gmpcapital.com
Address: GMP Capital Inc.
145 King Street West,
Suite 300,
Toronto,
Ontario, M5H 1J8,
Canada
Listings
Exchange Symbol Ticker Symbol Security Exchange Country Currency Listed on
TSX GMP Common Stock The Toronto Stock Exchange CA CAD 09. Dec 2003
OTCPK GMPX.F Common Stock Pink Sheets LLC US USD 09. Dec 2003
DB G04 Common Stock Deutsche Boerse AG DE EUR 09. Dec 2003
TSX GMP.PRB PFD-B 5YR REST The Toronto Stock Exchange CA CAD 22. Feb 2011
Number of employees
Current staff
Staff numbers
213
GMP Capital employees.
Industry
Investment Banking and Brokerage
Diversified Financials
Company Analysis and Financial Data Status
Area Date (UTC time)
Company Analysis updated: 2019/03/20 00:22
End of day share price update: 2019/03/19 00:00
Last estimates confirmation: 2017/03/03
Last earnings filing: 2019/03/01
Last earnings reported: 2018/12/31
Last annual earnings reported: 2018/12/31


All dates and times in UTC. All financial data provided by Standard & Poor’s Capital IQ.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.